(KO Validated) HIF1AN Polyclonal Antibody

(KO Validated) HIF1AN Polyclonal Antibody

Catalog Number:
A001511103RED
Mfr. No.:
RD86836A
Price:
$450
  • Size:
    Quantity:
    Add to Cart:
      • Overview
        • Calculated MW: 14kDa
          Observed MW: 14kDa/16kDa

          Please contact us at for specific academic pricing.

          Background

          Hydroxylates HIF-1 alpha at 'Asn-803' in the C-terminal transactivation domain (CAD. Functions as an oxygen sensor and, under normoxic conditions, the hydroxylation prevents interaction of HIF-1 with transcriptional coactivators including Cbp/p300-interacting transactivator. Involved in transcriptional repression through interaction with HIF1A, VHL and histone deacetylases. Hydroxylates specific Asn residues within ankyrin repeat domains (ARD of NFKB1, NFKBIA, NOTCH1, ASB4, PPP1R12A and several other ARD-containing proteins. Also hydroxylates Asp and His residues within ARDs of ANK1 and TNKS2, respectively. Negatively regulates NOTCH1 activity, accelerating myogenic differentiation. Positively regulates ASB4 activity, promoting vascular differentiation.

      • Properties
        • Host
          rabbit
          Antibody Type
          polyclonal
          Isotype
          IgG
          Reactivity
          human; mouse; rat
          Immunogen
          Recombinant fusion protein of human HIF1AN
          Purification
          Affinity purification
          Conjugate
          Unconjugated
          Formulation
          PBS with 0.05% proclin300,50% glycerol,pH7.3.
          Storage
          Store at -20°C Valid for 12 months. Avoid freeze-thaw cycles.
          Concentration
          1 mg/mL
          Antigen
          HIF1AN, FIH1 (Gene ID:55662; UniProt:Q9NWT6)

          * For reference only.

      • Applications
        • Application
          WB; IF
        • Application Dilutions
          WB 1:500-1:2000
          IF 1:50-1:200

    Note: If you don't receive our verification email, do the following:

    Copyright © Amerigo Scientific. All rights reserved.